Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Sales Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Sales Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Net Sales Growth(%) 12.771.98-5.8612.442.85

What is the latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS is 12.77 based on Mar2025 Consolidated results.
Year Net Sales Growth
Mar202512.77
Mar20241.98
Mar2023-5.86
Mar202212.44
Mar20212.85

How is Net Sales Growth of GLENMARK PHARMACEUTICALS Trending?

Years Net Sales Growth % Change
Mar2025 12.77
544.95
Mar2024 1.98
Positive
Mar2023 -5.86
Negative
Mar2022 12.44
336.49
Mar2021 2.85 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Net Sales Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹55,614.6 Cr -1% -3.7% 32.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,488.0 Cr -2.5% -7% -8% Stock Analytics
DIVIS LABORATORIES ₹159,415.0 Cr -2.2% -7.2% 1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,906.0 Cr -4% 2.8% 27.1% Stock Analytics
CIPLA ₹106,210.0 Cr -5.5% -12.4% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,089.0 Cr 5.9% -3.7% -6.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1%

-3.7%

32.7%

SENSEX

-2.4%

-4.7%

6.4%


You may also like the below Video Courses